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Question: Does 12 weeks of progressive, resistance exercise 
administered during haemodialysis improve skeletal muscle 
quality and quantity, muscle strength, exercise capacity, 
and quality of life compared with standard care? Design: 
Randomised, controlled trial with concealed allocation and 
blinded assessment of primary outcomes. Setting: Outpatient 
haemodialysis unit of an Australian hospital. Participants: 
Adults who had received haemodialysis for more than three 
months, were independently ambulant > 50 m, and were 
able to perform resistance exercises. Randomisation of 
49 subjects allotted 24 to the intervention group and 25 to 
standard care. Interventions: Both groups received standard 
medical care. In addition the intervention group undertook 
two sets of eight repetitions of 10 different exercises for the 
major muscle groups of the upper and lower limbs in supine 
or sitting during each dialysis session, three times per week 
for 12 weeks. This was performed to a rating of perceived 
exertion of hard to very hard. The arm used for vascular 
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access was exercised immediately before each haemodialysis 
session. Outcome measures: The primary outcomes were 
the change from baseline to 12 weeks of thigh muscle cross 
sectional area (muscle quantity) and the intramuscular lipid 
infiltration using computed tomography scan (a measure 
of muscle quality where a reduction in Hounsfield units 
represents improvement). Secondary outcome measures 
were strength of the knee extensors, hip abductors, and 
triceps measured using a digital dynamometer and summed 
to give a total score; exercise capacity measured using a 
six-minute walk test; C reactive protein assayed from blood 
samples; anthropometric measures; and quality of life 
using the SF-36. Results: 44 subjects (90%) were followed 
up. Change in muscle quantity did not differ significantly 
between groups but the change in muscle quality, –0.4 
Hounsfield units (95% CI –0.8 to 0.0), significantly favoured 
the intervention group. Changes in the intervention group 
were also significantly better for total muscle strength by 
18 kg (95% CI 9 to 26); C reactive protein by log –0.32 
(95% CI –0.53 to –0.11); and two domains of quality of life: 
physical function by 9 (95% CI 1 to 18), and vitality by 10 
(95%CI 1 to 19). Changes in body weight, BMI and mid arm 
and mid thigh circumference were also significantly better 
in the intervention group. Conclusions: Twelve weeks of 
progressive resistance training during routine haemodialysis 
showed clinically meaningful benefits.
Commentary
Muscle atrophy is extremely common amongst patients 
with end-stage renal disease (Kouidi 1998). It may occur 
as a consequence of acidosis, corticosteroid use, oxidative 
stress, and disturbances due to haemodialysis. Disuse 
is another major contributory factor, with reductions in 
daily activity and formal exercise participation due to 
both musculoskeletal sequelae of renal disease (cramps, 
myoclonus, fatigue) and the prolonged periods devoted to 
haemodialysis. This further reduces function and quality of 
life.
Evidence of the beneficial effects of exercise training in this 
population has been accumulating since the 1980s (Nakao 
1982, Goldberg 1983, Shalom 1984, Castellino 1987). One 
previous trial has investigated resistance training during 
routine haemodialysis treatment (Johansen 2006). That 
factorial trial demonstrated improvement in quadriceps 
muscle cross-sectional area in response to exercise training 
– an effect that was still evident even when the anabolic 
steroid nandrolone decanoate was used as a co-intervention. 
Unfortunately, an improvement in lean body mass was not 
identified, since this correlates with long-term survival in 
haemodialysis patients (Desmeules 2004).
The current study extends knowledge in this area by 
examining a more comprehensive (full body) and higher 
intensity exercise intervention. Previously identified 
improvements in muscle strength were confirmed, however 
the effect on muscle cross-sectional area was not statistically 
significant. The increases in total strength, body weight, body 
mass index, and limb circumference were both statistically 
significant and clinically worthwhile. It is unfortunate that 
lean body mass was not measured directly since it is an 
excellent prognostic indicator (Desmeules 2004).
The current study is of excellent quality, scoring 8/10 on 
the PEDro scale (Maher 2003) and with patient compliance 
over 80%. Hopefully this will increase physiotherapy 
involvement in the haemodialysis unit and provision of this 
worthwhile intervention, which has not received the active 
promotion it deserves in many haemodialysis units world-
wide.
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